Research Protocol Summary Study Protocol: 0.25 mg AOD-9604 administered intra-articularly via ultrasound guidance Frequency: Weekly injections Duration: 4-7 weeks in research studies Combination Therapy: 6 mg hyaluronic acid co-administered for enhanced effects Assessment Timeline: Significant improvements observed by 8-9 weeks Note: These protocols are from animal research and have not been validated for human use
Elevation after an injection can also linger, partly for a chemical reason
Rather than relying on a single isolated pathway, this formulation integrates two highly stable synthetic peptides BPC-157 Arginate Salt and KPV with two lipid-derived homeostatic modulators, Palmitoylethanolamide (PEA) and Tributyrin
Once the carrier confirms your medication has been delivered, the process is considered complete
Even though peptide therapy clears your system within hours, the tissue repair and signaling restoration it initiates continues well beyond a single dose
The inclusion of benzyl alcohol inhibits microbial growth between successive punctures, qualifying this product as a multi-dose diluent suitable for repeated access under aseptic conditions